Atlas Trials

A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease

Clinical trial NCT00350545 · COMPLETED

Trial details

NCT number
NCT00350545
Sponsor
Stanford University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Graft vs Host Disease
Start date
2006-08-01
Primary completion
2012-05-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.